JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Scope & Guideline
Unlocking the mysteries of infection and immunity.
Introduction
Aims and Scopes
- Clinical Microbiology and Infectious Diseases:
The journal emphasizes research on various infectious diseases, including bacterial, viral, and fungal pathogens. Studies often focus on clinical characteristics, treatment outcomes, and antimicrobial resistance patterns. - Immunology and Host Response:
Research that explores the immune response to infections, vaccine efficacy, and the interplay between pathogens and the host's immune system is a central theme. This includes studies on T-cell responses, antibody production, and immunological markers. - Antimicrobial Resistance:
A significant focus is placed on understanding the mechanisms and epidemiology of antimicrobial resistance, particularly among gram-negative bacteria and other clinically relevant pathogens. This includes studies on resistance genes, phenotypic resistance, and the impact of antimicrobial stewardship. - Epidemiology and Public Health:
The journal publishes research that investigates the epidemiological trends of infectious diseases, including outbreaks, risk factors, and population-based studies that inform public health strategies. - Innovative Diagnostic Methods:
Research on novel diagnostic techniques, including molecular methods like PCR and metagenomics, is also highlighted, reflecting the journal's commitment to improving diagnostic accuracy and speed for infectious diseases.
Trending and Emerging
- COVID-19 Research:
Research related to COVID-19, including its clinical manifestations, treatment protocols, and long-term sequelae, has surged. This reflects the pandemic's significant impact on global health and the urgent need for understanding its implications. - Antimicrobial Stewardship and Resistance:
There is an increasing focus on studies addressing antimicrobial stewardship programs, strategies to combat antimicrobial resistance, and the development of novel antimicrobial agents. - Long COVID and Post-Infectious Syndromes:
Emerging studies on Long COVID and other post-infectious syndromes are gaining attention, highlighting the need for ongoing research into the long-term effects of viral infections. - Vaccine Development and Response:
Research on vaccine efficacy, safety, and the immune response to various vaccines, especially in immunocompromised populations, is trending, reflecting the global emphasis on vaccination as a public health strategy. - Microbiome Studies:
Investigation into the role of the microbiome in health and disease, particularly its interaction with infectious agents and impact on treatment outcomes, is gaining traction.
Declining or Waning
- Non-Infectious Disease-Related Immunology:
Research focusing solely on immunology without a direct connection to infectious diseases appears to be waning. The journal's current trend favors studies that link immunological mechanisms to infectious disease outcomes. - Traditional Laboratory Techniques:
There is a noticeable decline in studies relying solely on traditional microbiological techniques, such as culture-based methods, as newer, more rapid diagnostic methods gain traction. - Epidemiological Studies of Established Pathogens:
Epidemiological research on well-established pathogens, which previously received significant attention, is becoming less frequent as emerging pathogens and their associated diseases take precedence. - Localized Studies:
Studies focused on localized outbreaks or regional infections without broader implications or connections to global health concerns are less common, possibly due to a shift towards research with wider applicability.
Similar Journals
MIKROBIYOLOJI BULTENI
Pioneering Insights in Immunology and MicrobiologyMIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.
JOURNAL OF CLINICAL MICROBIOLOGY
Empowering Professionals with High-Impact InsightsJOURNAL OF CLINICAL MICROBIOLOGY, published by the American Society for Microbiology, stands as a premier resource for researchers and professionals in the field of medical microbiology. With an illustrious history dating back to 1975, this journal has consistently provided high-impact research, reflecting its status in the Q1 category among microbiology (medical) journals, and an impressive Scopus rank of 14 out of 140, placing it in the 90th percentile. The journal's commitment to unveiling foundational and innovative studies greatly contributes to understanding human health challenges posed by microbial pathogens. Researchers can expect rigorous peer-reviewed articles that cover a spectrum of topics, from diagnostic methods to clinical epidemiology, fostering a deeper understanding of microbiology's role in healthcare. While this journal does not offer open access options, its substantial impact factor underscores its relevance in shaping the conversation in clinical microbiology. The JOURNAL OF CLINICAL MICROBIOLOGY is indispensable for anyone dedicated to advancing their knowledge and practical skills in microbiology.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Advancing the Frontiers of Infectious Disease DiagnosticsDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.
MICROBES AND INFECTION
Unveiling the Secrets of Microbial BehaviorMICROBES AND INFECTION is a premier academic journal published by Elsevier, dedicated to the dynamic fields of immunology, infectious diseases, and microbiology. With a notable impact factor reflective of its high-quality research contributions, the journal is categorized in the Q2 quartile across these fields as of 2023. Based in France and operating since 1999, MICROBES AND INFECTION offers a platform for researchers, professionals, and students to disseminate and access cutting-edge findings that drive innovation and knowledge in microbial and infectious disease research. The journal is ranked impressively within the Scopus database, securing ranks such as #16 in Microbiology and #33 in Infectious Diseases, underscoring its high relevance in the scientific community. Subscribers to the journal can expect an array of articles, reviews, and original research, all designed to advance understanding and improve clinical practices in the fight against infectious agents. With its ongoing commitment to open access options, MICROBES AND INFECTION continues to foster global collaboration and information sharing in the pursuit of addressing pressing microbiological challenges.
MICROBIOLOGY AND IMMUNOLOGY
Exploring the Frontiers of Microbial and Immune ScienceMICROBIOLOGY AND IMMUNOLOGY, an esteemed journal published by WILEY, serves as a vital resource for researchers and professionals in the fields of microbiology, immunology, and virology. With its ISSN 0385-5600 and E-ISSN 1348-0421, this journal has been a cornerstone in scientific literature since its inception in 1977, bridging decades of research and innovation through its comprehensive coverage of emerging trends and discoveries. Although this journal operates without open access, it maintains a commendable presence in academic circles, reflected in its 2023 Quartile rankings of Q3 across the categories of Immunology, Microbiology, and Virology. As part of an important discourse in these disciplines, MICROBIOLOGY AND IMMUNOLOGY ensures its scholarly contributions are relevant to both seasoned researchers and emerging scholars. Positioned in a competitive journal landscape, with Scopus ranks indicating a median percentile across its fields, it remains committed to advancing knowledge through peer-reviewed articles, thereby supporting the continuous evolution of its focus areas. The journal's current scope encompasses topics critical for understanding pathogen-host interactions and the immune response, making it a crucial publication for any academic library or individual scholar dedicated to the biological sciences.
New Microbes and New Infections
Bridging gaps in understanding novel infectious agents.New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.
JOURNAL OF INFECTIOUS DISEASES
Connecting Research to Practice in Infectious Disease CareThe JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.
Archives of Clinical Infectious Diseases
Advancing the Frontiers of Infectious Disease ResearchArchives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.
GERMS
Championing research that transforms health outcomes worldwide.GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.
New Microbiologica
Connecting science and health through groundbreaking microbiological studies.New Microbiologica is a prominent academic journal published by EDIZIONI INT SRL, dedicated to advancing knowledge in the fields of Microbiology and Medicine. Since its inception in 1993, this journal has played a vital role in disseminating cutting-edge research, featuring articles that explore the intricate relationships between microorganisms and human health. With an H-index indicating a robust citation profile and a respectable 2023 Scopus Ranking placing it in the 32nd percentile for medicine microbiology, New Microbiologica resonates well within the academic community. Although not an Open Access journal, it is strategically positioned in Quartile 3 of both Medicine (miscellaneous) and Medical Microbiology categories, which reflects its importance to researchers and professionals seeking valuable insights in their fields. Published in Italy, the journal continues to provide a platform for impactful research through its commitment to high-quality publications, fostering collaboration and innovation among scientists and academics in the ever-evolving landscape of microbiological studies.